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Abstract Genogroup II.4 norovirus (NoV) remains the
predominant NoV strain in food- and water-borne out-
breaks. Capsid integrity as well as viral RNA persistence
were determined for GII.4 NoV by real-time RT-PCR after
1–14 freeze/thaw (F/T) cycles (-80 C/?22 C) or after
-80 C storage for up to 120 days. In both cases, capsid
integrity and viral RNA titers remained stable. RNase was
exogenously added after 1–14 F/T cycles, but did not alter
the amount of genomic NoV RNA detected, indicating that
capsids remained intact. Presumptive NoV infectivity was
evaluated in functional studies by a porcine gastric mucin
binding assay. Viruses frozen and thawed up to 149 bound
similarly to porcine mucin, suggesting no reduction in virus
infectivity. Overall, this study shows that a) NoV particles
retain their integrity for at least 14 F/T cycles, b) long-term
(120 day) frozen storage does not decrease NoV RNA
titers, and c) capsid binding to receptor-like glycoprotein
moieties remains unaltered after 14 F/T cycles. This work
indicates that freezing and thawing of foods or beverages
would not be a practical processing intervention to reduce
NoV contamination. Likewise, repeated freezing and
thawing, as might be encountered during winter months, is
not expected to inactivate NoV in the environment. Results
do show that laboratory samples destined for molecular
biological analyses or for use as positive controls may be
repeatedly frozen and thawed without any anticipated
reduction in NoV RNA titers. This study documents the
cryostability of NoV capsids and RNA to freezing and
thawing and to the possible retention of virus infectivity.
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Introduction
Human norovirus (NoV) is the principle cause of food-
borne illness in the United States with an incidence
recently estimated at 5.5 million cases annually (Scallan
et al. 2011). Water-borne illnesses from NoV are estimated
to be even higher than food-borne illnesses (Mead et al.
1999). Genogroup II clade 4 (GII.4) NoV is the most
prevalent strain worldwide accounting for about 80 % of
illnesses (Donaldson et al. 2008; Siebenga et al. 2007,
2009; Hall et al. 2011). Noroviruses contain single stran-
ded, positive sense, RNA genomes of 7.7 kb surrounded by
an icosahedral capsid 27–40 nm in diameter. Reverse-
transcription-PCR remains the only practical method to
detect human strains of NoV in food, environmental, and
clinical samples since these viruses cannot be propagated
in traditional cell culture systems or in animal models. The
RNA genome of NoV is normally protected by a resilient
capsid, but damage to the capsid’s integrity makes the
RNA molecule highly susceptible to degradation by
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ubiquitous RNases in the environment. Thus, the integrity
of the capsid is fundamental to the integrity of viral RNA.
Only a limited number of studies have assessed the
effects of freezing duration or freezing and thawing on
human NoV. Such studies have practical application in
identifying: a) potential food processing techniques to
eliminate NoV in foods and beverages, b) environmental
conditions conducive to the inactivation of NoV, and c)
methods for the preservation of viruses for use in NoV
testing laboratories. Butot et al. (2008) showed minimal
losses in feline calicivirus titers in berries and herbs after
90 days of frozen storage with more acidic foods causing
greater decreases. Feline caliciviruses are a commonly used
surrogate for human NoV. Mormann et al. (2010) evaluated
GII.3 NoV RNA reduction after various processing treat-
ments in experimentally contaminated foods. They showed
that there was no significant reduction in RNA levels in
pizza or mincemeat after freezing and storage at -18 C
for 14 days. NoV outbreaks have been associated with ice
(Cannon et al. 1991; Khan et al. 1994; Levine et al. 1990),
and in recent years, have been particularly problematic
after the consumption of frozen raspberries (Cotterelle
et al. 2005; Falkenhorst et al. 2005; Sarvikivi et al. 2011).
Therefore, frozen products are common vectors of human
NoV illness.
No studies have been performed to evaluate the persis-
tence of GII.4 NoV after repeated freeze–thaw (F/T)
cycles; therefore, the effects of freezing and thawing on
NoV, as would be encountered under certain environmental
conditions, are unclear. It is possible that NoV in lakes,
streams, and coastal areas may be affected by freezing and
thawing although a strikingly higher incidence of NoV
illness occurs during the winter months and is what led to
the earlier name for NoV illness as ‘‘winter vomiting dis-
ease’’ (McSwiggan et al. 1978). Increased winter outbreaks
may be associated with enhanced virus persistence in cold
climates, less sunshine and ultraviolet irradiation to inac-
tivate virus particles during the winter, or a generally lower
resistance to illness among the population at large.
Some laboratory conditions under which NoV-contain-
ing samples are stored or preserved involve freezing and
thawing even though freezing and thawing might be
expected to compromise capsid integrity. Uncertainty
about the effects of freezing and thawing on NoV capsid
integrity has led to differences in the way laboratories
preserve virus-containing specimens. For instance, NoV-
containing stools from outbreak investigations are main-
tained in the refrigerator at many testing laboratories,
pending analysis. Specimens are presumed to last for
extended periods under these conditions although mold can
overgrow the specimens. Other laboratories maintain
specimens frozen until tested. For NoV analysis by
RT-PCR, samples containing NoV are often aliquoted,
frozen, and thawed as few times as possible, and used
either as test samples, research materials, or positive con-
trols. The need to maintain viral RNA titers in the labo-
ratory is of paramount importance so further information is
needed on the stability of NoV to freezing and to repeated
cycles of freezing and thawing. If capsids lose their
integrity from freezing and thawing or repeated freezing
and thawing, then RNA titers, as determined by molecular
methods, would decrease.
In this paper, we demonstrate that single or repeated
cycles of freezing and thawing of diluted NoV stool stocks
have no demonstrable effect on NoV titers even after
RNase treatment. In addition, we show that NoV stool
dilutions maintain their ability to bind to porcine gastric




Fresh stools were provided to the Delaware Division of
Public Health Laboratory for routine norovirus screening
after outbreaks of gastroenteritis in long-term care facili-
ties. All stools were sequence confirmed to contain GII.4
NoV (New Orleans) and the high-titered stools were
reserved at 4 C for this study. Stools used in this study
showed high titer by end-point dilution RT-PCR (C1 9
109 RT-PCR units/ml) as determined by the method
described in Richards et al. (2004). For NoV stock prepa-
ration and titration, stools were diluted 10-fold in
sterile, nuclease-free water, vortex mixed, centrifuged at
10,0009g for 10 min, and serially filtered through sterile
Millex-HV 0.45- and Millex-GV 0.22-lm Teflon, low
protein binding syringe filters (Millipore, Billerica, MA,
USA). These NoV ‘‘filtered stocks’’ were maintained at
4 C until use.
Freeze/Thaw
For each of two experiments, fourteen 500-ll tubes were
each inoculated with 225 ll of filtered NoV stock and
placed in a -80 C freezer. Initially, samples were stored
for up to 120 days at -80 C with weekly or bi-weekly
analysis after a single, slow (30 min) thaw at room tem-
perature (about 22 C). Thawing of all tubes was con-
ducted at room temperature in styrofoam racks to insure
slow thawing and to maximize damage of viral capsids
from ice crystals. Complete thawing was achieved within
30 min. The RNA was extracted from samples, and the
extracts were tested in triplicate by real-time RT-PCR, as
described below.
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A second set of 14 tubes was repetitively frozen at
-80 C and slowly thawed at room temperature at weekly
intervals over the course of 14 weeks such that tubes
underwent from 1–14 F/T cycles. At the designated weekly
interval, the repeatedly frozen and thawed samples were
thawed as a group. Tubes were transferred to another rack
for storage at -80 C when their designated number of F/T
cycles was reached. Remaining tubes from that group were
refrozen at -80 C to await additional F/T cycles. Thaw-
ing was performed for 30 min for each time interval. One
final thaw was performed on all samples at the end of the
study and samples were subjected to viral RNA extraction
and analysis by RT-PCR.
Viral RNA Extraction
Using 140 ll of stool filtrate, NoV RNA was extracted,
column purified, and eluted in 60 ll of water using a
Qiamp Viral RNA Mini Kit (Qiagen Inc., Valencia, CA,
USA) according to the manufacturer’s instructions. Posi-
tive controls consisted of similar NoV RNA extracts from
the same stool filtrates, except samples were never frozen.
For samples frozen and thawed, 140 ll were similarly
extracted, concentrated to 60 ll, and assayed by real-time
RT-PCR.
Norovirus Real-Time RT-PCR
Real-time RT-PCR was performed on a Smart Cycler
(Cepheid, Sunnyvale, CA, USA) using the one step RT-PCR
Kit (Qiagen). Primers were as follows: forward primer
QNIF2 (50-ATGTTCAGRTGGATGAGRTTCTCWGA-30)
(Loisy et al. 2005), where R = A or G and W = A or T;
reverse primer COG2R (50-TCGACGCCATCTTCATTC
ACA-30) (Kageyama et al. 2003). The probe was as descri-
bed by Loisy et al. (2005), designated QN1FS, but Texas Red
was substituted on the 50 end and Black Hole Quencher 2
(BHQ-2) was on the 30 end as follows: 50-TexRed-
AGCACGTGGGAGGGGATCG-BHQ-2-30. Primers and
probe were synthesized by Integrated DNA Technologies
(Skokie, IL, USA). Final RT-PCR concentrations were
250 nM probe, 500 nM forward primer, 900 nM reverse
primer, 5 ll buffer, 1 ll dNTPs, 1 ll enzyme mix, 5 U of
RNase inhibitor (Invitrogen, Carlsbad, CA, USA), 12.25 ll
nuclease-free H2O, and 1 ll viral RNA extract (template).
Reverse transcription was performed at 50 C for 30 min,
followed by Taq activation for 15 min at 95 C and then 50
cycles of PCR amplification at 95 C for 15 s and 60 C for
1 min. Negative controls consisted of master mix including
primers with water substituted for the NoV stool extracts.
Positive controls were as described above. Norovirus RNA
titers of the diluted stool filtrates were monitored by real-
time RT-PCR. Cycle threshold (Ct) values were measured at
an arbitrary threshold of 30 fluorescence units at the end of
each 60 C extension step. All aliquots were compared
among each other for relative Ct values. All extracts were
tested by real-time RT-PCR in triplicate.
RNase Treatments
The integrity of the NoV capsid to repeated (1–14) F/T
cycles was monitored after the addition of exogenous
RNase (RNace-it Ribonuclease Cocktail, Stratagene, La
Jolla, CA, USA), which contained 2 lg/ll of RNase A and
4 U/ll of nonspecific RNase from Aspergillus oryzae. In
this study, 150 ll of filtered NoV stock was added to each
of 15-0.5 ml tubes. A non-frozen control was maintained in
the refrigerator while the remaining tubes were frozen at
-80 C for C2 h. Thawing was performed at room tem-
perature for 30 min in a styrofoam rack. At the end of the
appropriate number of F/T cycles, all tubes were thawed
and treated with 2 ll of RNace-it Ribonuclease cocktail to
digest any viral RNA exposed by the freezing and thawing.
Each tube was mixed by gentle vortexing, spun 2 s, and
incubated at room temperature for 30 min. RNase inhibitor
was added (5 ll = 50 U) to each tube to stop the reaction,
and the samples were again mixed and spun for 2 s. After
5 min, the tubes were added to ice pending RNA extraction
by Qiamp Viral RNA Mini Kit (Qiagen) and assay by RT-
PCR. This trial was performed in duplicate and each
extract was tested by RT-PCR in duplicate (n = 4). Pre-
viously, this RNase treatment was demonstrated to effec-
tively eliminate all traces of NoV RNA in RNA extracts
derived from the filtered NoV stock.
Mucin-Binding Study
Fourteen 0.5-ml tubes were inoculated with 150 ll of fil-
tered NoV stock. Tubes were frozen at -80 C and slowly
thawed at room temperature 1–149, as described above.
Porcine gastric mucin-conjugated magnetic beads (PGM-
MBs) were prepared as previously described (Dancho et al.
2012). Binding studies were performed according to the
procedures of Dancho et al. (2012) with the exception that
a saturation titration curve was not included. Accordingly,
infectious NoVs have greater binding affinities toward
mucin-conjugated beads than non-infectious capsids
(Dancho et al. 2012). Fifty microliters from each tube was
diluted 1:20 by addition to 950 ll of PBS in duplicate.
Fifty microliters of PGM-MBs were added to the 950 ll of
diluted sample followed by rotational mixing at 8 rpm at
room temperature for 30 min. A magnetic bead attractor
(Stratagene) was used to separate the PGM-bound NoV
from the unbound. The unbound viruses in the aqueous
phase were removed from the bead extractor and kept
on ice, while the viruses bound to the beads were washed
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39 with 1 ml PBS containing 10 U of RNase inhibitor
(Invitrogen). Heat release and concentration of the virus
particles from the beads was accomplished by the addition
of 50 ll of PBS followed by heating at 99 C for 5 min.
The magnetic beads were removed from the heat-released
viruses using the magnetic bead attractor. Samples were
placed on ice pending RT-PCR of the bound and unbound
fractions. The trial was performed in duplicate for each
sample and relative quantification of extracted RNA was
based on observed Ct values by real-time RT-PCR, which
was performed in duplicate.
Virus Quantification
In preliminary testing, it was determined that there was
little to no change in the levels of NoV amplicon after 14
FT cycles; therefore, Ct values were judged a good mea-
sure for relative changes in titers over the course of this
study. Significant differences in NoV RNA levels were
calculated by Student’s t-tests.
Results
Norovirus-Filtered Stock
The titers of the 1:10 diluted and filtered GII.4 NoV stocks
used throughout this study were C1 9 108 RT-PCR units/
ml so the titers of the original, undiluted stools were
C1 9 109 RT-PCR units/ml. For each 10-fold dilution of
the filtered NoV stocks, the Ct value increased by a mean
of 3.5 Ct units.
Single Versus Multiple Freeze Thaws
The effect of storage duration at -80 C was evaluated
using an initial freeze and then a single, room temperature
thaw at weekly or bi-weekly intervals for 17 weeks
(120 days), followed by immediate viral RNA extraction
and real-time RT-PCR analysis. The relative viral RNA
titers of the extracts remained essentially the same over the
17-week trial period (Fig. 1a). For the multiple freeze/thaw
experiment, aliquots were frozen and thawed up to 149.
Relative viral RNA levels remained essentially the same,
as judged by relative Ct values (Fig. 1b) for those thawed
1–149. The mean Ct values for the aliquots frozen and
thawed only once were not significantly different from the
values derived from aliquots which were repeatedly frozen
and thawed (Fig. 1a, b respectively). The precision of the
results was high given the very small standard deviation
bars in Fig. 1 (mentioned as too small to be seen in the
figure legend) and later in Fig. 3 (where only some were
large enough to be visualized). Overall, there was no
reduction in NoV titer observed for either experiment; the
mean titer of the initial sample before freezing (Ct = 20.05)
was not significantly different (P [ 0.05) from the mean
titers of the samples frozen once (Ct = 20.25) or up to 149
(Ct = 20.36).
Retention of Capsid Integrity
To confirm that repeated F/T cycles do not release the viral
RNA from the virion, RNase was added to assess whether
the capsid was capable of protecting the viral genome from
enzymatic destruction. Norovirus was frozen (-80 C) and
slowly thawed (?22 C) from 1–149 followed by the
addition of commercially obtained RNase cocktail after the
designated number of F/T cycles. After incubation for
30 min, RNase inhibitor was added and viral RNA was
extracted and assayed. Unfrozen NoV stock filtrate served
as a control. Results confirm no loss of NoV RNA titers
over 14 F/T cycles (Fig. 2). The initial, unfrozen titer (0
F/T) was not significantly different (P [ 0.05) from the
titer after 14 F/T cycles (mean Ct values of 20.6 and 21.2,
respectively). Some increases in Ct values (suggesting
about a 1-log and 0.5-log decrease in titer) were observed
at 7 and 8 F/T cycles in one of the trials, but are attributed
Fig. 1 Relative cycle threshold (Ct) values for GII.4 norovirus in
water after a frozen storage and a single thaw weekly or every two
weeks (biweekly) for up to 17 weeks (120 days) and b frozen storage
and up to 14 freeze–thaw cycles at weekly or biweekly intervals. SD
bars are too small to be seen
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to the variability in column extraction of the NoV RNA
since Ct values remained low and nearly constant from 2 to
6 and 9–14 F/T cycles (Fig. 2).
Retention of Capsid Function
A recently developed porcine gastric mucin binding assay,
which measures the ability of the intact capsid to bind to
receptor-like glycoproteins was employed as an indicator
of potential NoV infectivity. Bound and unbound NoVs
showed no significant change (P [ 0.05) in binding effi-
ciency over 14 F/T cycles (Fig. 3). The mean Ct value for
the bound and unfrozen control was 21.6 compared with
the bound sample which was frozen and thawed 149 and
which gave a Ct of 22.1. The mean Ct values for the
unbound, unfrozen control and for the unbound sample that
had been frozen and thawed 149 were 26.7 and 27.2,
respectively. In total, the data presented here suggest that
neither the integrity nor the infectivity of GII.4 NoV in an
aqueous stool suspension was significantly affected by up
to 14 F/T cycles.
Discussion
To our knowledge, this is the first time that the effects of
multiple F/T cycles on human NoV have been evaluated and
results conclude that freezing and thawing does not affect
capsid integrity or the RNA titer. Evidence that NoV RNA
remains encapsidated after freezing and thawing is sup-
ported by the fact that unfrozen samples and samples
frozen and thawed only once over the course of 17 weeks
(120 days) contained essentially the same levels of viral
RNA as samples frozen and thawed up to 149. Freezing
followed by slow thawing at room temperature would be
expected to exert maximum damage to viral capsids from
prolonged exposure to ice crystals. If F/T damage had sub-
stantially affected the capsid’s integrity, then the viral RNA
would have been destroyed by ubiquitous RNases present in
stool filtrates. These RNases would include a variety of
endo- and exonucleases from both human and bacterial
cells in the gut. While RNases are considered very hardy
enzymes, it is conceivable that RNases from the stool fil-
trates could be damaged and inactivated after repeated F/T
cycles. Consequently, we performed additional tests where a
commercially obtained RNase cocktail was added to NoV
after 1–14 F/T cycles. It showed that there was also no
reduction in virus titer after repeated freezing and thawing.
Another line of evidence for capsid integrity is predicated
on the ability of viable viruses to bind to porcine gastric
mucin. It is well established that the detection of viral RNA
does not indicate the presence of infectious viruses, because
virus infectivity also depends on the retention of capsid
protein conformation (Richards 1999). For a NoV to initiate
an infection, the capsid must mediate binding of the virion to
a host cell via a receptor and the virion must subsequently
enter the cell and release the positive-sense RNA genome
into the cytosol. Essentially, the porcine mucin binding assay
is a proxy for the first step in the replication process (e.g.,
receptor binding). Previous work has shown that NoV sub-
jected to thermal, UV, and high pressure treatments retain
capsid integrity; however, the treatments damage the capsid
and prevent capsid binding to mucin (Dancho et al. 2012). In
this paper, we have extended earlier work to show that
repeated freezing and thawing does not affect the capsid’s
ability to bind to mucin, suggesting that multiple F/T cycles
do not reduce NoV infectivity. The absolute confirmation of
virus infectivity would require an assessment using human
volunteers.
Overall, we conclude that NoV GII.4 is highly resistant
to repeated F/T cycles and to long-term storage. It is
uncertain if other genogroups or clades of NoV offer
this same cryostability. Our results, showing the persistence
of NoV to long-term freezing, are consistent with a NoV
volunteer study which demonstrated that GI.1 NoV (Nor-
walk strain 8FIIa) retained infectivity after frozen storage
Fig. 2 Two independent trials showing GII.4 norovirus persistence in
water after 0–14 freeze/thaw cycles followed by the addition of
RNase cocktail. Relative cycle threshold (Ct) values were determined
in triplicate for each trial
Fig. 3 Binding of frozen and thawed GII.4 norovirus to porcine
mucin. Relative cycle threshold (Ct) values for porcine mucin-bound
(filled circle) and unbound (empty square) norovirus, where binding
may be a predictor of norovirus infectivity. Bars indicate SD
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for more than two decades (Teunis et al. 2008). In contrast,
a study using the propagatable NoV surrogate, feline
calicivirus, showed some virus sensitivity to repeated F/T
cycles (Duzier et al. 2004), suggesting that this surrogate
may not be representative of human NoV. One should be
careful in using surrogate data to predict a response for
human NoV since surrogates often do not mimic the
viruses they represent (Richards 2012).
The persistence of NoV to freezing and thawing is
unwelcome news in food processing and for the elimination
of NoV from the environment. For foods potentially con-
taminated with NoV, such as produce and shellfish, there is
no evidence to suggest that freezing and thawing will have a
beneficial effect on reducing virus infectivity. In fact, food
matrix and proteins would be expected to further stabilize
NoV over water alone. Thus, we conclude that freezing and
thawing are unsuitable as a food processing intervention for
NoV. Likewise, our results indicate that winter freezing and
thawing events are not likely to contribute to the inactivation
of environmental NoVs. However, this persistence of NoV
to freezing and thawing is welcome news in the laboratory,
where samples destined for analysis or to be used as positive
controls may be repeatedly frozen and thawed without any
anticipated reduction in viral RNA titers.
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